Pathobiological Determinants of Atherosclerosis in Youth (PDAY)

This study has been completed.
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00005679
First received: May 25, 2000
Last updated: February 17, 2016
Last verified: January 2008
  Purpose
To conduct a multicenter prevalence survey for characterizing pathologically the extent of atherosclerosis in the aortas and coronary arteries of young persons dying from accidental causes, suicide, or homicide.

Condition
Cardiovascular Diseases
Atherosclerosis
Heart Diseases
Coronary Disease
Coronary Arteriosclerosis

Study Type: Observational

Resource links provided by NLM:


Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: June 1985
Study Completion Date: July 1993
Primary Completion Date: July 1993 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   15 Years to 34 Years   (Child, Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
No eligibility criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005679

Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Investigators
OverallOfficial: Arthur Chandler Georgia Regents University
OverallOfficial: J. Cornhill Ohio State University
OverallOfficial: Asaad Daoud Albany Medical College
OverallOfficial: Morton Friedman Ohio State University
OverallOfficial: Steffen Gay University of Alabama at Birmingham
OverallOfficial: James Hixson Southwest Foundation for Biomedical Research
OverallOfficial: Singanallur Jagannathan West Virginia University Medical Center
OverallOfficial: C. McMahan University of Texas
OverallOfficial: Wolfgang Mergner University of Maryland
OverallOfficial: Edward Miller University of Alabama at Birmingham
OverallOfficial: Stanley Radio University of Nebraska
OverallOfficial: Dennis Reichebach University of Washington
OverallOfficial: Abel Robertson University of Illinois at Chicago
OverallOfficial: Louis Smith Baylor College of Medicine
OverallOfficial: Jack Strong Louisiana State University Medical Center
OverallOfficial: Renu Virmani Vanderbilt University School of Medicine
OverallOfficial: Robert Wissler University of Chicago
  More Information

Publications:

ClinicalTrials.gov Identifier: NCT00005679     History of Changes
Other Study ID Numbers: 1049  R10HL033772 
Study First Received: May 25, 2000
Last Updated: February 17, 2016
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cardiovascular Diseases
Heart Diseases
Atherosclerosis
Coronary Disease
Coronary Artery Disease
Arteriosclerosis
Myocardial Ischemia
Arterial Occlusive Diseases
Vascular Diseases

ClinicalTrials.gov processed this record on July 26, 2016